Advertisement
News
Subscribe to MDT Magazine News

CareFusion 2Q profit rises, company pares outlook

February 3, 2011 5:45 pm | by The Associated Press | Comments

Medical device maker CareFusion Corp. said Thursday its profit increased 9 percent in the fiscal second quarter as cost cuts offset a decline in sales.The company said its profit rose to $76 million, or 34 cents per share, from $70 million, or 32 cents per share. Excluding items like...

FDA sued over shipments of drug used in executions

February 3, 2011 12:45 pm | by GREG BLUESTEIN - Associated Press - Associated Press | Comments

A federal lawsuit filed against the Food and Drug Administration urges a judge to block overseas shipments of a key drug used in the nation's executions that has been in short supply since the sole U.S. maker decided to stop producing it.The lawsuit filed Wednesday in federal court in Washington,...

US agency sued over drug used in executions

February 3, 2011 12:45 pm | by GREG BLUESTEIN - Associated Press - Associated Press | Comments

A federal lawsuit filed against the Food and Drug Administration urges a judge to block overseas shipments of a key drug used in the nation's executions that has been in short supply since the sole U.S. maker decided to stop producing it.The lawsuit filed Wednesday in federal court in...

Advertisement

Using a generic blood pressure and heart drug could save the UK $324 million in 2011

February 3, 2011 12:38 pm | by EurekAlert | Comments

(Wiley-Blackwell) Using a generic drug to treat hypertension and heart failure, instead of branded medicines from the same class, could save the UK's National Health Service at least £200 ($324) million in 2011 without any real reduction in clinical benefits. That is the key...

TOPICS:

Death in the bat caves: Disease wiping out hibernating bats

February 3, 2011 11:39 am | by EurekAlert | Comments

(Wiley-Blackwell) Conservationists across the United States are racing to discover a solution to white-nose syndrome, a disease that is threatening to wipe out bat species across North America. A review published in Conservation Biology reveals that although WNS has already killed...

TOPICS:

CareFusion to sell unit for $130M to Medline

February 3, 2011 10:45 am | by The Associated Press | Comments

CareFusion Corp. said Thursday it will sell its surgical products unit to privately-held Medline Industries for $130 million.CareFusion's surgical products business is based in based in Rolle, Switzerland, with operations in 16 European and Asian-Pacific countries and distribution and assembly...

Microchips moves osteoporosis device into clinical study

February 3, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Some 18 years after MIT professor Robert Langer first envisioned using an implantable reservoir as a drug delivery device, one of his companies, MicroCHIPS Inc. of Bedford, announced today that it is initiating a clinical study of a device that delivers a peptide over the course of months...

ConforMIS knee replacement tech get FDA marketing nod

February 3, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Burlington-based medical devices company ConforMIS Inc. has received 510k clearance from the U.S. Food and Drug Administration to commercially market its iTotal CR Knee Replacement System.

Advertisement

Psivida eyes opportunities in off-patent drugs

February 3, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

PSivida Corp. of Watertown is breathing new life into off-patent drugs by using them with its miniaturized drug-delivery products, which deliver lower, time-released doses of therapies for longer periods. And it's scheduled today to release three-year data from two Phase 3 clinical trials...

Summary Box: Cigna's 4Q profit jumps 40 pct

February 3, 2011 8:45 am | by The Associated Press | Comments

THE RESULTS: Health insurer Cigna Corp. earned $461 million, or $1.69 per share, for the fourth quarter. That's up from $330 million, or $1.19 per share, a year earlier. Revenue grew 17 percent to $5.43 billion. Adjusted earnings excluding some one-time items amounted to $1.15 per...

LAB Research under review by TSX for continued listing on exchange

February 3, 2011 8:45 am | by The Associated Press | Comments

LAB Research Inc. (TSX:LRI) is under review by the Toronto Stock Exchange to ensure it is meeting the requirements of a continued listing.

Dollars + STEM Education = Job Creation

February 3, 2011 8:36 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., January 31, 2011 — In a recent study, the Kauffman Foundation found that in any given year, the top-performing one percent of firms is generating roughly 40 percent of all new jobs. The SME Education Foundation accelerated its efforts through relationships with this...

Microchips moves osteoporosis device into trial

February 3, 2011 8:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Some 18 years after MIT professor Robert Langer first envisioned using an implantable reservoir as a drug delivery device, one of his companies, MicroCHIPS Inc. of Bedford, announced today that it is initiating a clinical study of a device that delivers a peptide over the course of months...

Carrot Medical Reports 2010 Growth in Sales and Financing, Optimism for 2011

February 3, 2011 7:33 am | by Bio-Medicine.Org | Comments

BOSTON, Feb. 3, 2011 /- Carrot Medical, a leading designer of integrated medical imaging display systems, has announced results for 2010. During the year, Carrot Medical achieved significant growth in sales, an expansion of sales channels and secured additional private financing. Carrot...

TOPICS:

Curemark Hosts New York Senator Kirsten Gillibrand

February 3, 2011 7:32 am | by Bio-Medicine.Org | Comments

RYE, N.Y., Feb. 3, 2011 /- Curemark, LLC , ( www.curemark.com ), a drug research and development company focused on the treatment of neurological diseases, recently hosted New York Senator Kirsten Gillibrand as she announced a new proposal to spur innovation and job creation, locally and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading